🔎 Trials Near Me

Akèy › Obèsite › Maryland › Baltimore

Etid klinik pou Obèsite nan Baltimore, MD

25 etid pou Obèsite ap chèche patisipan nan sit nan ak bò kote Baltimore (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Ap rekriteFaz 3
  • Barry J. Reiner, MD LLC, Baltimore
Laj 8 a 18 · Tout sèks · Mizajou Sep 30, 2026 · NCT07253285

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Ap rekriteFaz 3
  • Ascension Saint Agnes Heart Care, Baltimore
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07595549

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Ap rekriteFaz 3
  • Johns Hopkins Children's Center, Baltimore
Laj 6 a 17 · Tout sèks · Mizajou Sep 24, 2026 · NCT06672549

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Ap rekriteFaz 3
  • Ascension Saint Agnes Heart Care, Baltimore
Laj 45 a 99 · Tout sèks · Mizajou Sep 22, 2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Ap rekriteFaz 3
  • MedStar Good Samaritan Hospital, Baltimore
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07321886

A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants

Ap rekriteFaz 1Volontè an sante akeyi
  • Research Site, Brooklyn · 4 mi lwen
Laj 18 a 55 · Tout sèks · Mizajou Sep 16, 2026 · NCT07723833

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Ap rekriteFaz 3
  • Ascension Saint Agnes Heart Care, Baltimore
  • Johns Hopkins University, Baltimore
Laj 18 a 99 · Tout sèks · Mizajou Sep 16, 2026 · NCT07037459

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Ap rekriteFaz 3
  • Baltimore VA Medical Center, Baltimore
  • Johns Hopkins University School of Nursing, Baltimore
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07351045

A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1043 in Healthy Adult Participants Living With Overweight and/or Obesity.

Ap rekriteFaz 1Volontè an sante akeyi
  • Research Site, Brooklyn · 4 mi lwen
Laj 18 a 65 · Tout sèks · Mizajou Sep 9, 2026 · NCT07511205

A Research Study Investigating How a New Medicine NNC0113-5840 Works in People With Overweight or Obesity

Ap rekriteFaz 1
  • PAREXEL Intl - EPCU-Baltimore, Baltimore
Laj 18 a 55 · Tout sèks · Mizajou Sep 9, 2026 · NCT07566390

Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder

Ap rekriteFaz 2
  • Johns Hopkins University, Baltimore
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06847399

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Ap rekriteFaz 3
  • Kailera Clinical Site, Annapolis · 22 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT07284901

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Ap rekriteFaz 3
  • Ascension Saint Agnes Heart Ca, Baltimore
  • Mercy Medical Center, GI Research, Baltimore
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT07567001

Understanding and Addressing Risks of Low Socioeconomic Status and Diabetes for Heart Failure

Ap rekrite
  • Johns Hopkins Center for Health Equity, Baltimore
Laj 30 a 70 · Tout sèks · Mizajou Jul 15, 2026 · NCT06364644

Healthy for Two-Home Visiting (H42-HV): Health Coaching for Pregnant Women

Ap rekrite
  • Johns Hopkins School of Nursing, Baltimore
Laj 18 ak plis · Fanm · Mizajou Jun 8, 2026 · NCT05619705

A Phase 1/2a Study of WVE-007 in Adults Living With Overweight or Obesity

Ap rekriteFaz 1/2Volontè an sante akeyi
  • Parexel International-EPCU Baltimore, Baltimore
Laj 18 a 60 · Tout sèks · Mizajou Jun 2, 2026 · NCT06842186

Modifying Adiposity Through Behavioral Strategies to Improve COVID-19 Rehabilitation

Ap rekriteVolontè an sante akeyi
  • Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD, Baltimore
Jiska laj 80 · Tout sèks · Mizajou Jun 1, 2026 · NCT05880108

Health Promotion With Targeted Exercise Intervention for Decreasing Fall Risk and Inactivity in Aging Veterans With Obesity and Signs of Sarcopenia

Ap rekrite
  • Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD, Baltimore
Laj 55 ak plis · Tout sèks · Mizajou Apr 21, 2026 · NCT07206368

Dinner Time for Obesity and Prediabetes

Ap rekriteVolontè an sante akeyi
  • Johns Hopkins Bayview Medical Center, Baltimore
Laj 18 a 50 · Tout sèks · Mizajou Apr 13, 2026 · NCT05745441

Trial of Food Is Medicine Approaches for Obesity Treatment in Adults With Food Insecurity

Ap rekrite
  • Johns Hopkins University, Baltimore
Laj 18 ak plis · Tout sèks · Mizajou Mar 16, 2026 · NCT07396805

Metformin IN Asthma for Overweight and Obese Individuals (MINA)

Ap rekriteFaz 2
  • Johns Hopkins University, Baltimore
Laj 18 ak plis · Tout sèks · Mizajou Jan 16, 2026 · NCT06273072

Metabotyping of Broccoli Microgreen in Obese Breast Cancer Survivors

Ap rekrite
  • Breast Evaluation and Treatment Program, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore
Tout laj · Fanm · Mizajou Dec 23, 2025 · NCT07032545

Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM0504 Tablets in Non-diabetic Overweight or Obese Adult Subjects

Ap rekriteFaz 1
  • Pharmaron CPC, Inc, Baltimore
Laj 18 a 65 · Tout sèks · Mizajou Sep 19, 2025 · NCT07166081

Etid Obèsite nan lòt vil

Lòt etid nan Baltimore

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.